Acland et al., 1990 - Google Patents
Subcellular fate of the lnt-2 oncoprotein is determined by choice of initiation codonAcland et al., 1990
- Document ID
- 4908861566812156252
- Author
- Acland P
- Dixon M
- Peters G
- Dickson C
- Publication year
- Publication venue
- Nature
External Links
Snippet
FIBROBLAST growth factors (FGFs) have been implicated in many aspects of cell growth and differentiation both in normal and neoplastic settings1, 2. For example, the mouse int-2 gene, which encodes an FGF-related product3, is a frequent target of proviral activation in …
- 229920000978 Start codon 0 title abstract description 8
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
- C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICRO-ORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING OR MAINTAINING MICRO-ORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
- C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
- C12N15/79—Vectors or expression systems specially adapted for eukaryotic hosts
- C12N15/85—Vectors or expression systems specially adapted for eukaryotic hosts for animal cells
- C12N15/8509—Vectors or expression systems specially adapted for eukaryotic hosts for animal cells for producing genetically modified animals, e.g. transgenic
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
- C07K16/18—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
- C07K16/28—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/705—Receptors; Cell surface antigens; Cell surface determinants
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/475—Growth factors; Growth regulators
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/82—Translation products from oncogenes
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K38/00—Medicinal preparations containing peptides
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K2319/00—Fusion polypeptide
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K48/00—Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| Acland et al. | Subcellular fate of the lnt-2 oncoprotein is determined by choice of initiation codon | |
| Windle et al. | Retinoblastoma in transgenic mice | |
| ES2261429T3 (en) | PROTOONCOGEN 2 OF UTERO NECK HUMAN CANCER AND THE PROTEIN THAT CODIFIES. | |
| US7341996B2 (en) | Processed vascular endothelial growth factor-B polypeptides | |
| ES2273438T3 (en) | NAME CYTOKIN LERK-6. | |
| US6569420B2 (en) | Human interferon-ε: a type I interferon | |
| US6235713B1 (en) | Vascular endothelial growth factor-D (VEGF-D) polypeptides | |
| JP5285513B2 (en) | Angiogenesis inhibitor | |
| JP2002518018A (en) | Erythropoietin analog-human serum albumin fusion | |
| JP2014111624A (en) | Artery- and vein-specific proteins and use methods therefor | |
| JPH06507782A (en) | Non-human recombinant mammals exhibiting amyloid formation symptoms of Alzheimer's disease | |
| US5670134A (en) | Method for evaluating and modifying biological activity | |
| TW205069B (en) | ||
| US7504483B2 (en) | α-β C4BP-type recombinant heteromultimeric proteins | |
| TW200427472A (en) | Device comprising VGF polypeptides | |
| JP2007510625A (en) | LIM2 inhibitor of LMO2 | |
| EP0948536B1 (en) | A g protein-coupled receptor with an enlarged extracellular domain | |
| ES2277335T3 (en) | DESIGNATED CYTOQUINE LERK-6. | |
| EP0731166A2 (en) | Novel calcium-binding proteins | |
| DE69925271T2 (en) | ANGIOSTATIN-BINDING PROTEIN | |
| Hoffman et al. | Retrovirus-mediated transfer of an adenovirus gene encoding an integral membrane protein is sufficient to down regulate the receptor for epidermal growth factor | |
| Bunnag et al. | Transformed phenotype conferred to NIH/3T3 cells by ectopic expression of heparin-binding growth factor 1/acidic fibroblast growth factor | |
| US6333171B1 (en) | CD4 gene regulatory sequences specifically expressed in mature T cells | |
| EP0511816B1 (en) | Neurotrophic peptide derivative | |
| WO1989004871A1 (en) | Improvements relating to the production of monoclonal antibodies |